52 year old man
Recurrent, Progressive, Adenoid Cystic Carcinoma (ACC), Stage IV with metastases to lung
From: Minnesota, United States
Diagnosis: Recurrent, Progressive Adenoid Cystic Carcinoma (ACC) Stage IV; extensive involvement at nasal septum with multiple metastasis to the lung
Treatment: Treatments and Outcomes: At large well-known medical center he first underwent surgery to remove the nasal tumor – required three surgeries; followed by chemoradiation therapy with remission. Upon recurrence, considered unresponsive to chemotherapy. He then began treatment an evidence-based, molecularly-targeted Cancer Wellness Plan®MD treatment protocol developed by Dr. LaValley specifically for him and his cancer cell type. His local Integrative Medicine specialist administered the treatment plan successfully.
- Two years later recurrence in lung treated with chemotherapy; tumor stabilized and did not progress until 6 months later; 3 months later tumor progression continued;
- He then consulted an integrative medicine specialist in mid 2011 who implemented a molecularly-targeted Cancer Wellness Plan®MD treatment protocol developed by Dr. LaValley specifically for him.
Outcome: Clinical course to present day (as of August 15, 2016).
- Over one year later the CT scan showed decrease in the size of all the metastatic lesions in the lung with no new lesions.
- Six months later ongoing continued shrinkage with no new metastatic lesions;
- Six months later, the dominant nodule showed slight increase in size from 7 to 9 mm in dimension, all other lesions stable, no new lesions.
- Four months and seven months later CT scans showed no new lesions, all lesions stable except slight increase in the single dominant nodule.
- Two months later PET/CT showed active lesion in only the single dominant nodule. All other lesions stable in size and not seen to be metabolically active.
- Over the next two years no new lesions, all lesions stable except the dominant single nodule slightly increased to 10m by 11mm in November 2015.
Additional Treatment: Additional treatment options under consideration including Stereotactic Body Radiation Therapy (SBRT), Intensity Modulated Radiation Therapy (IMRT), and surgery.
When I think about Dr. Will LaValley, I always think our of our cancer journey. We found Dr. LaValley when we had exhausted all of what traditional medicine had to offer and were wondering what to do. Cancer entered our life ironically on April Fool’s Day 2008, even though my husband had been an aggressively healthful person, eating only the “right” things and exercising regularly for decades. We thought cancer was gone after 3 surgeries, as well as extensive chemo and radiation.
It was May 2010 when cancer returned as stage 4 with many lesions in the lungs. We visited fancy hospitals in Boston, New York, Minnesota and Texas. All were telling us to “plan our affairs.” We researched on line to find the most aggressive treatment and visited the traditional “best” providers and undertook intensive chemo again. The lesions got smaller; but by the summer of 2011, they were back.
We researched literally all over the world for something more effective than the traditional best. We found Dr. LaValley. He brought a fresh perspective, informed by years and years of cutting edge research, and fresh hope to our situation. My husband started his Anti-Cancer Protocol in July of 2011 and by the fall the lesions were as small as they had been following chemo. The Protocol had been as effective as chemo. His oncology team at the Mayo Clinic was – and still is – in awe!
Better yet, for the last four years, my husband’s stage 4 cancer has been stable. We are now treating his cancer like diabetes, something we have to manage and live with. In my view, the Protocol saved my husband’s life, and saved our family. Now, I believe our 4 year old and 14 year old daughters will have their father actively in their life for a long, long time.
THANK YOU, Dr. LaValley (and our local treating physician implementing the treatment) for the protocol you developed.SE, patient's wife